EFFECT OF FAMOTIDINE ON HYPOGLYCAEMIC ACTIVITY OF GLIBENCLAMIDE
DOI:
https://doi.org/10.22159/ijcpr.2026v18i1.8025Keywords:
Famotidine, Glibenclamide, Hypoglycaemic, Blood sugarAbstract
Objective: To study the effect of famotidine (H2 receptor antagonist) in combination with Glibenclamide on the blood sugar level in rabbits.
Methods: Six albino rabbits were taken for the study. Glibenclamide was administrated to each rabbit as a single drug therapy on day 1, while was co-administrated with Famotidine to each rabbit as a combinational drug therapy on day 7. Famotidine was administrated to each rabbit from day 2 to day 6 as a single drug therapy. Blood sugar levels were estimated on day 1 and on day 7 at 0, 1, 2, 4, and 6 h.
Results: The mean blood sugar level readings at 0, 1, 2, 4 and 6 h on day 1 were 91.1, 79.7, 70.6, 61.8 and 66.5 mg% and on day 7 were 91.1, 78.5, 69.6, 60.6 and 64.9 mg%, respectively. When blood sugar level on day 1 and 7 were compared, there was. no significant change in any of the readings after co-administration of Glibenclamide and Famotidine.
Conclusion: Famotidine did not produce any significant reduction in Blood sugar level when it was co-administered with glibenclamide
Downloads
References
1. Van Dalem J, Brouwers MC, Stehouwer CD, Krings A, Leufkens HG, Driessen JH. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population-based cohort study. BMJ. 2016;354:i3625. doi: 10.1136/bmj.i3625.
2. Lin JH, Chremos AN, Chiou R, Yeh KC, Williams R. Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers. Br J Clin Pharmacol. 1987;24(5):669-72. doi: 10.1111/j.1365-2125.1987.tb03228.x, PMID 2893637.
3. Vestal RE, Thummel KE, Musser B, Mercer GD. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. Br J Clin Pharmacol. 1983;15(4):411-8. doi: 10.1111/j.1365-2125.1983.tb01523.x, PMID 6849776.
4. Hetzel DJ, Bochner F, Hallpike JF, Shearman DJ, Hann CS. Cimetidine interaction with phenytoin. Br Med J (Clin Res Ed). 1981;282(6275):1512. doi: 10.1136/bmj.282.6275.1512, PMID 6786537.
5. Hetzel D, Birkett D, Miners J. Cimetidine interaction with warfarin. Lancet. 1979;2(8143):639. doi: 10.1016/s0140-6736(79)91701-x, PMID 90304.
6. Shep D, Phatak RS, Sidhu N, Gade P. Comparative effects of cimetidine on hypoglycaemic activity of glibenclamide in rabbits. Pravara Med Rev. 2019;11(4):5-8.
7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Famotidine. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIH); 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548228/. [Last accessed on 25 Jan 2018].
8. Ghosh. Fundamental of experimental pharmacology. 2nd ed; 2008. p. 154-5.
9. Ranjeeta Gholve D, Shep, Prakashchandra Gade, Manish Ramavat. A study on drug-drug interaction between glipizide and cimetidine in rabbits. Int J Curr Pharm Res. 2021;13(2):17-8. doi: 10.22159/ijcpr.2021v13i2.41545.
10. Gholve R, John S, Shep D, Ramavat M, effect of ranitidine on hypoglycaemic activity of glipizide in rabbits. Int J Curr Pharm Res. 2024;16(5):76-7. doi: 10.22159/ijcpr.2024v16i5.5069.
11. Chremos AN. Pharmacodynamics of famotidine in humans. Am J Med. 1986;81(4B):3-7. doi: 10.1016/0002-9343(86)90593-0, PMID 2877572.
12. Locniskar A, Greenblatt DJ, Harmatz JS, Zinny MA, Shader RI. Interaction of diazepam with famotidine and cimetidine two H2-receptor antagonists. J Clin Pharmacol. 1986;26(4):299-303. doi: 10.1002/j.1552-4604.1986.tb03527.x, PMID 2871051.
13. Daly AK. Pharmacogenetics of drug metabolism. Pharmacol Ther. 2017;175:148-62. doi: 10.1016/j.pharmthera.2017.02.010.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.